Comparison of inhaled salbutamol with placebo (water for inj.) on recovery process of newborns' transient tachypnea

Comparison of inhaled salbutamol With placebo (water for inj.) as an add-therapies on the duration of stay of newborns and the Recovery process of tachypnea and o2 dependence in transient tachypnea of Newborns in NICU in Qom hospitals: a clinical trial study

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190503043457N1

Enrollment

Registered

2019-05-28

Start date

2018-03-21

Completion date

Unknown

Last updated

2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transient tachypnea of Newborns. Transient tachypnoea of newborn

Interventions

Intervention 1: Intervention group: Receiving Salbutamol at a dose of 0.15 mg/kg body weight in 4 cc normal saline by nebulizer for 10 minutes. Intervention 2: Control group: Receiving four cc distil

Eligibility

Sex/Gender

All

Age

1 Days to 7 Days

Inclusion criteria

Inclusion criteria: A healthy term newborn with mild to moderate respiratory distress

Exclusion criteria

Exclusion criteria: Multiple anomalies Severe infection Metabolic disease

Design outcomes

Primary

Measure	Time frame
Number of breaths. Timepoint: 30 minutes, one and four hours after treat. Method of measurement: By physician based on the number of breaths per minute.;Percent saturation of oxygen. Timepoint: 30 minutes, one and four hours after treat. Method of measurement: By pulse oximetry.;Heart rate. Timepoint: 30 minutes, one and four hours after treat. Method of measurement: By pulse oximetry.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad mahmoudi

Ghoum University of Medical Sciences

u.hedayati@gmil.com+98 25 3665 1801

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026